12.25

0.24% -0.03

Korro Bio Inc (KRRO)

Panoramica Notizia Cronologia dei prezzi Forum Previsione

Precedente Chiudi:

$12.28

Aprire:

$11.86

Volume 24 ore:

169.77K

Relative Volume:

0.96

Capitalizzazione di mercato:

$176.68M

Reddito:

$6.39M

Utile/perdita netta:

$-117.26M

Rapporto P/E:

-0.9815

EPS:

-12.4807

Flusso di cassa netto:

$-79.08M

1 W Prestazione:

-15.87%

1M Prestazione:

+10.86%

6M Prestazione:

+39.52%

1 anno Prestazione:

-11.42%

Intervallo 1D:

$11.50

$12.36

Intervallo di 1 settimana:

$11.50

$14.46

Portata 52W:

$5.2044

$55.89

Korro Bio Inc Stock (KRRO) Company Profile

Nome

Korro Bio Inc

Settore

Healthcare (1092)

Industria

Biotechnology (603)

Telefono

617-468-1999

Indirizzo

60 FIRST STREET, CAMBRIDGE

Dipendente

Cinguettio

Prossima data di guadagno

2026-08-11

Ultimi documenti SEC

KRRO's Discussions on Twitter

Compare KRRO vs VRTX, REGN, ARGX, RVMD, ALNY

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
KRRO Korro Bio Inc	12.25	177.11M	6.39M	-117.26M	-79.08M	-12.48
VRTX Vertex Pharmaceuticals Inc	485.65	123.36B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	676.69	71.18B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	860.55	53.68B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	186.16	38.09B	742.00K	-1.37B	-1.07B	-7.0731
ALNY Alnylam Pharmaceuticals Inc	267.47	37.80B	4.29B	577.22M	641.34M	4.2086

Korro Bio Inc Stock (KRRO) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-03-13	Aggiornamento	Raymond James	Mkt Perform → Outperform
2026-02-17	Aggiornamento	William Blair	Mkt Perform → Outperform
2026-01-29	Aggiornamento	Chardan Capital Markets	Neutral → Buy
2026-01-29	Aggiornamento	H.C. Wainwright	Neutral → Buy
2026-01-29	Aggiornamento	Piper Sandler	Neutral → Overweight
2026-01-28	Aggiornamento	Cantor Fitzgerald	Neutral → Overweight
2026-01-28	Aggiornamento	Oppenheimer	Perform → Outperform
2025-11-13	Downgrade	Cantor Fitzgerald	Overweight → Neutral
2025-11-13	Downgrade	Chardan Capital Markets	Buy → Neutral
2025-11-13	Downgrade	H.C. Wainwright	Buy → Neutral
2025-11-13	Downgrade	Piper Sandler	Overweight → Neutral
2025-11-13	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
2025-11-13	Downgrade	Raymond James	Strong Buy → Mkt Perform
2025-11-13	Downgrade	William Blair	Outperform → Mkt Perform
2025-04-29	Iniziato	Cantor Fitzgerald	Overweight
2025-04-16	Iniziato	Chardan Capital Markets	Buy
2025-01-10	Iniziato	Oppenheimer	Outperform
2024-10-21	Iniziato	Raymond James	Strong Buy
2024-08-14	Iniziato	William Blair	Outperform
2024-03-28	Reiterato	H.C. Wainwright	Buy
2024-02-27	Iniziato	BMO Capital Markets	Outperform
2023-12-04	Iniziato	H.C. Wainwright	Buy
2023-11-29	Iniziato	RBC Capital Mkts	Outperform
2023-11-10	Iniziato	Piper Sandler	Overweight
2023-02-15	Downgrade	Chardan Capital Markets	Buy → Neutral
2023-02-13	Downgrade	Cowen	Outperform → Market Perform
2021-09-22	Downgrade	Goldman	Buy → Neutral
2021-01-27	Aggiornamento	JP Morgan	Neutral → Overweight
2020-12-22	Iniziato	B. Riley Securities	Buy
2020-07-14	Iniziato	Oppenheimer	Outperform
2020-05-18	Downgrade	JP Morgan	Overweight → Neutral
2019-10-28	Iniziato	Cowen	Outperform
2019-10-28	Iniziato	Goldman	Buy
2019-10-28	Iniziato	JP Morgan	Overweight

Mostra tutto

Korro Bio Inc Borsa (KRRO) Ultime notizie

Jul 17, 2026

Form 4 Korro Bio Inc For: 17 July By Investing.com - Investing.com Nigeria

Jul 17, 2026